Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Ancitabine
2. Anhydro-ara-c
3. Cyclo C
4. Cyclo-c
5. Cycloc
6. Cyclocytidine
7. Nsc 145,668
8. Nsc 145668
9. Nsc-145,668
10. Nsc-145668
11. Nsc145,668
12. Nsc145668
13. U 33,624a
14. U 33624a
15. U-33,624a
16. U-33624a
17. U33,624a
18. U33624a
1. Cyclocytidine Hydrochloride
2. 10212-25-6
3. Cyclocytidine
4. 2,2'-o-cyclocytidine Hydrochloride
5. Cyclo-cmp Hydrochloride
6. Cyclocytidine Hcl
7. Octd Hydrochloride
8. Ancitabin Hydrochlorid
9. Ancitabine Hcl
10. Ancitabine (hydrochloride)
11. 2,2'-anhydrocytarabine Hydrochloride
12. 2,2'-anhydroaracytidine Hydrochloride
13. Nsc-145668
14. 2,2'-anhydro-1-beta-d-arabinofuranosylcytosine Hydrochloride
15. Ancitabine Hydrochloride [jan]
16. 2,2'-anhydroarabinosylcytosine Hydrochloride
17. (-)-cyclocytidine Hydrochloride
18. Cyclo-c
19. 2,2'-cyclocytidine Hydrochloride
20. Chebi:74843
21. 2,2'-anhydrocytidine Hydrochloride
22. 3t6920m469
23. (2r,3r,3as,9ar)-2-(hydroxymethyl)-6-imino-3,3a,6,9a-tetrahydro-2h-furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-3-ol Hydrochloride
24. Ancitabine Hydrochloride (jan)
25. Mls001173324
26. Ancitabin Hcl
27. Ancitabin Hydrochloride
28. Smr000538927
29. Einecs 233-515-6
30. 2,2'-cyclocytidine, Monohydrochloride
31. Nsc 145668
32. O-2,2'-cyclocytidine Monohydrochloride
33. Unii-3t6920m469
34. Mfcd00012636
35. 2,2'-anhydro-1beta-d-arabinofuranosylcytosine Hydrochloride
36. 1beta-d-arabinofuranosylcytosine, 2,2'-anhydro-, Hydrochloride
37. 1-beta-d-arabinofuranosylcytosine, 2,2'-anhydro-, Hydrochloride
38. Cytosine, 1-beta-d-arabinofuranosyl-2,2'-anhydro-, Hydrochloride
39. Cytosine, 1beta-d-arabinofuranosyl-2,2'-anhydro-, Hydrochloride
40. Schembl98180
41. Mls000766878
42. Mls001032024
43. Mls006011603
44. Nsc 145668 Hcl
45. Chembl1255937
46. Hy-n0093
47. 2,2'-cyclocytidine Monohydrochloride
48. Ancitabine Hydrochloride [mi]
49. S1973
50. Akos015896930
51. Ac-8697
52. Ccg-267066
53. Cs-5313
54. Ancitabine Hydrochloride [mart.]
55. Ancitabine Hydrochloride [who-dd]
56. 6h-furo(2',3':4,5)oxazolo(3,2-a)-pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-3-hydroxy-6-imino-, Monohydrochloride, Stereoisomer
57. 6h-furo(2',3':4,5)oxazolo(3,2-a)pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-3-hydroxy-6-imino-, Monohydrochloride, (2r-(2alpha,3beta,3abeta,9abeta))-
58. As-12870
59. Tl8000113
60. D01651
61. 698c143
62. J-700010
63. Q27144957
64. 2,2'-anhydro-(1-beta-d-arabinofuranosylcytosine) Hydrochloride
65. 2,2'-anhydro-1-(beta-d-arabinofuranosyl)cytosine Hydrochloride
66. Cyclocytidine Hydrochlorine; 2,2''-o-cyclocytidine Hydrochloride
67. (2r,3r,3as,9ar)-2,3,3a,9a-tetrahydro-3-hydroxy-6-imino-6h-furo(2',3';4,5)oxazolo(3,2-a)pyrimidine-2-methanol, Hydrochloride
68. (2r,3r,3as,9ar)-2-(hydroxymethyl)-6-imino-2,3,3a,9a-tetrahydro-6h-furo[2',3':4,5][1,3]oxazolo[3,2-a]pyrimidin-3-ol Hydrochloride
69. (2r,3r,3as,9ar)-2-(hydroxymethyl)-6-imino-2,3,3a,9a-tetrahydrofuro[1,2]oxazolo[3,4-a]pyrimidin-3-ol
70. (2r,3r,3as,9ar)-2-(hydroxymethyl)-6-imino-3,3a,6,9a-tetrahydro-2h-furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-3-olhydrochloride
Molecular Weight | 261.66 g/mol |
---|---|
Molecular Formula | C9H12ClN3O4 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 1 |
Exact Mass | 261.0516336 g/mol |
Monoisotopic Mass | 261.0516336 g/mol |
Topological Polar Surface Area | 98.4 Ų |
Heavy Atom Count | 17 |
Formal Charge | 0 |
Complexity | 394 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 4 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Antimetabolites, Antineoplastic
Antimetabolites that are useful in cancer chemotherapy. (See all compounds classified as Antimetabolites, Antineoplastic.)
ABOUT THIS PAGE
41
PharmaCompass offers a list of Cyclocytidine Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cyclocytidine Hydrochloride manufacturer or Cyclocytidine Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cyclocytidine Hydrochloride manufacturer or Cyclocytidine Hydrochloride supplier.
PharmaCompass also assists you with knowing the Cyclocytidine Hydrochloride API Price utilized in the formulation of products. Cyclocytidine Hydrochloride API Price is not always fixed or binding as the Cyclocytidine Hydrochloride Price is obtained through a variety of data sources. The Cyclocytidine Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Cyclocytidine Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cyclocytidine Hydrochloride, including repackagers and relabelers. The FDA regulates Cyclocytidine Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cyclocytidine Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Cyclocytidine Hydrochloride supplier is an individual or a company that provides Cyclocytidine Hydrochloride active pharmaceutical ingredient (API) or Cyclocytidine Hydrochloride finished formulations upon request. The Cyclocytidine Hydrochloride suppliers may include Cyclocytidine Hydrochloride API manufacturers, exporters, distributors and traders.
Cyclocytidine Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cyclocytidine Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cyclocytidine Hydrochloride GMP manufacturer or Cyclocytidine Hydrochloride GMP API supplier for your needs.
A Cyclocytidine Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Cyclocytidine Hydrochloride's compliance with Cyclocytidine Hydrochloride specifications and serves as a tool for batch-level quality control.
Cyclocytidine Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Cyclocytidine Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cyclocytidine Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Cyclocytidine Hydrochloride EP), Cyclocytidine Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cyclocytidine Hydrochloride USP).